Eisai Co Ltd (4523.T)
4523.T on Tokyo Stock Exchange
7,093JPY
19 Apr 2018
7,093JPY
19 Apr 2018
Change (% chg)
¥51 (+0.72%)
¥51 (+0.72%)
Prev Close
¥7,042
¥7,042
Open
¥7,059
¥7,059
Day's High
¥7,110
¥7,110
Day's Low
¥7,053
¥7,053
Volume
880,100
880,100
Avg. Vol
1,211,671
1,211,671
52-wk High
¥7,148
¥7,148
52-wk Low
¥5,402
¥5,402
Revenue & Earnings Per Share
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1 | 146,200.00 | 146,200.00 | 146,200.00 | -- |
| Quarter Ending Dec-18 | 1 | 157,500.00 | 157,500.00 | 157,500.00 | -- |
| Year Ending Mar-18 | 10 | 601,152.00 | 608,900.00 | 595,000.00 | 569,894.00 |
| Year Ending Mar-19 | 10 | 603,051.00 | 642,300.00 | 571,000.00 | 575,072.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | 46.48 | 46.48 | 46.48 | -- |
| Quarter Ending Dec-18 | 1 | 67.79 | 67.79 | 67.79 | -- |
| Year Ending Mar-18 | 11 | 194.50 | 201.23 | 182.56 | 126.17 |
| Year Ending Mar-19 | 11 | 187.30 | 277.67 | 124.72 | 128.61 |
| LT Growth Rate (%) | 2 | 20.28 | 21.16 | 19.40 | -7.29 |
Sales and Profit Figures in Japanese Yen (JPY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 69.44 | 30.61 | 33.50 | |
| P/E High - Last 5 Yrs. | 56.38 | 40.54 | 46.07 | |
| P/E Low - Last 5 Yrs. | 24.81 | 24.12 | 24.95 | |
| Beta | 0.71 | 0.81 | 0.80 | |
| Price to Sales (TTM) | 3.67 | 4.64 | 7.25 | |
| Price to Book (MRQ) | 3.41 | 4.03 | 5.09 | |
| Price to Tangible Book (MRQ) | 6.87 | 4.85 | 6.62 | |
| Price to Cash Flow (TTM) | 36.07 | 22.54 | 25.50 | |
| % Owned Institutions | -- | 1.17 | 2.24 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 2.13 | 1.63 | 1.53 | |
| Dividend Yield - 5 Year Avg | 2.56 | 0.73 | 0.75 | |
| Dividend 5 Year Growth Rate | 0.00 | 2.71 | 3.92 | |
| Payout Ratio(TTM) | 147.78 | 20.34 | 20.54 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 11.15 | 6.87 | 8.68 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 7.37 | 9.82 | 11.19 | |
| Sales - 5 Yr. Growth Rate | -3.61 | 7.66 | 8.22 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -11.63 | 19.83 | 22.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -47.22 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -7.72 | 8.96 | 10.28 | |
| Capital Spending - 5 Yr. Growth Rate | 0.52 | 9.68 | 10.41 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.82 | 2.53 | 2.53 |
| Current Ratio (MRQ) | 2.15 | 3.61 | 3.61 |
| LT Debt to Equity (MRQ) | 27.31 | 8.75 | 11.39 |
| Total Debt to Equity (MRQ) | 39.07 | 11.04 | 14.02 |
| Interest Coverage (TTM) | 67.25 | 46.23 | 39.28 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 64.16 | 54.69 | 54.05 | |
| Gross Margin - 5 Yr. Avg. | 66.08 | 52.13 | 52.18 | |
| EBITD Margin (TTM) | 13.00 | -- | -- | |
| EBITD - 5 Yr. Avg | 16.73 | 18.41 | 15.90 | |
| Operating Margin (TTM) | 8.45 | 12.81 | 4.09 | |
| Operating Margin - 5 Yr. Avg. | 10.01 | 14.18 | 11.23 | |
| Pre-Tax Margin (TTM) | 8.25 | 13.05 | 4.81 | |
| Pre-Tax Margin - 5 Yr. Avg. | 9.53 | 14.53 | 11.54 | |
| Net Profit Margin (TTM) | 5.61 | 9.46 | 1.42 | |
| Net Profit Margin - 5 Yr. Avg. | 8.11 | 10.86 | 7.87 | |
| Effective Tax Rate (TTM) | 32.03 | 22.48 | 30.96 | |
| Effective Tax Rate - 5 Yr. Avg. | 14.92 | 23.66 | 24.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 54,517,220 | 918,428,665 | 813,295,447 | |
| Net Income/Employee (TTM) | 3,058,745 | 107,983,553 | 95,590,786 | |
| Receivable Turnover (TTM) | 3.15 | 5.60 | 5.56 | |
| Inventory Turnover (TTM) | 2.50 | 2.55 | 3.44 | |
| Asset Turnover (TTM) | 0.55 | 0.91 | 0.89 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 3.06 | 10.94 | 10.51 | |
| Return on Assets - 5 Yr. Avg. | 4.55 | 12.13 | 11.54 | |
| Return on Investment (TTM) | 3.90 | 13.57 | 13.17 | |
| Return on Investment - 5 Yr. Avg. | 5.71 | 15.68 | 14.94 | |
| Return on Equity (TTM) | 4.91 | 15.25 | 14.98 | |
| Return on Equity - 5 Yr. Avg. | 8.39 | 16.85 | 16.23 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -1.61 | -3.48 | -3.61 |
| EPS (TTM) % | -28.34 | 0.84 | -7.72 |
| Dividend % | 0.00 | 0.00 | 0.00 |
Note: Units in Millions of US Dollars
Performance for Eisai Co Ltd
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 3.44 | 1.46 | 99 | 67 |
| 13 Week | 9.21 | 18.02 | 99 | 41 |
| 26 Week | 17.15 | 15.48 | 99 | 20 |
| 52 Week | 24.18 | 4.44 | 99 | 20 |
| YTD | 9.76 | 14.02 | 99 | 26 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Nichi-Iko Pharmaceutical says business and capital alliance with Eisai
- BRIEF-Anticancer Agent Lenvima Approved For Additional Indication Of Unresectable Hepatocellular Carcinoma In Japan
- Eisai clinches Merck deal to develop and sell cancer drug, shares soar
- CORRECTED-UPDATE 3-Eisai clinches Merck deal to develop and sell cancer drug, shares soar
- BRIEF-Eisai Co, Merck Announce Oncology Collaboration For Lenvima
Institutional Holders
| % Shares Owned: | 40.33% |
| # of Holders: | 232 |
| Total Shares Held: | 119,601,196 |
| 3 Mo. Net Change: | -10,216,648 |
| # New Positions: | 2 |
| # Closed Positions: | 3 |
| # Increased Positions: | 50 |
| # Reduced Positions: | 45 |
| # Net Buyers: | 5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.